+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biologics Market - Global Forecast 2025-2030- Product Image
Biologics Market - Global Forecast 2025-2030- Product Image
Sale

Biologics Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082738
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biologics market is undergoing rapid transformation as healthcare innovation and investment fuel new therapeutic approaches, creating critical opportunities and challenges for senior leaders navigating an increasingly complex ecosystem.

Market Snapshot: Biologics Market Growth & Strategic Significance

The Biologics Market grew from USD 430.59 billion in 2024 to USD 459.45 billion in 2025. It is expected to continue growing at a CAGR of 6.45%, reaching USD 626.76 billion by 2030. This trajectory highlights biologics as a central force in reshaping disease management—especially for complex and chronic conditions—driven by increasing demand for precision therapies and healthcare ecosystem modernization. The market's expansion is underpinned by investments from both established pharmaceutical companies and nimble biotechnology ventures, supporting continued clinical and commercial breakthroughs in advanced biologics modalities.

Scope & Segmentation

  • Product Types: Blood Factor Products, CAR-T Therapies, Stem Cell Therapy, Gene Therapies, Monoclonal Antibodies, Recombinant Proteins, Vaccines.
  • Technology Types: Cell Culture Technology, CRISPR, TALENs, Zinc Finger Nucleases, Hybridoma Technology, Recombinant DNA Technology, Gene Editing Technology.
  • Routes of Administration: Intramuscular, Intravenous, Subcutaneous.
  • Therapeutic Areas: Autoimmune, Cardiovascular Diseases, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Oncology.
  • End Users: Clinics, Home Healthcare, Hospitals, Research Institutes.
  • Distribution Channels: Hospital Pharmacy, Online Channel, Retail Pharmacy.
  • Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Saudi Arabia, South Africa, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, Southeast Asia).
  • Companies Profiled: Roche Holding AG, AbbVie Inc., Pfizer Inc., Johnson & Johnson, Novartis AG, Merck & Co., Inc., Sanofi S.A., Amgen Inc., Bristol-Myers Squibb Company, Gilead Sciences, Inc.

Key Takeaways for Senior Decision-Makers

  • Ongoing advances in molecular technologies and digital health platforms support more efficient development, validation, and real-world evidence generation for high-value biologics.
  • Growth is not uniform worldwide; regional markets are shaped by varying regulatory frameworks, healthcare investments, and demographic needs, requiring adaptive go-to-market strategies.
  • Strategic partnerships—spanning biotech innovators, pharma leaders, and academic institutions—are vital for pipeline diversification and accelerating clinical progress.
  • Manufacturing flexibility and supply chain resilience are becoming competitive differentiators, with new modalities requiring agile production and distribution networks.
  • Intellectual property management and robust regulatory intelligence provide critical protection and commercial advantage across global markets.
  • Patient engagement and data-driven approaches increasingly influence product design, clinical trial execution, and post-market strategies.

Tariff Impact on Biologics Supply Chain

Tariff policy changes in the United States in 2025 have introduced complexities for biologics manufacturers. Increased import duties on key inputs are driving reassessment of sourcing strategies and encouraging diversification of supplier bases. Many organizations are emphasizing regional production hubs and onshoring initiatives to mitigate cost and logistics risks, while cross-border operations are being optimized to maintain margins and supply continuity. Regulatory harmonization efforts and closer engagement with industry associations are supporting strategic responses to these evolving policy dynamics.

Methodology & Data Sources

This research employs a methodology that combines primary interviews with senior executives, regulatory specialists, and clinical researchers, supplemented by analysis of scientific literature, regulatory filings, and financial disclosures. Data validation utilizes multi-source verification and cross-regional triangulation to support credible and actionable market insights.

Why This Report Matters

  • Empowers executives to benchmark competitive strategy, manage risk, and maximize opportunity within a rapidly evolving global biologics market.
  • Offers granular segmentation, facilitating targeted investment and resource allocation aligned to current therapeutic and technological trends.
  • Delivers evidence-based analysis, supporting informed decision-making under today’s dynamic regulatory and economic conditions.

Conclusion

As the biologics market advances through continual innovation and shifting global dynamics, purposeful strategy and adaptability are essential for sustained leadership. This report equips stakeholders with the insights needed to capitalize on complex opportunities and manage future risks effectively.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of biosimilar interchangeability guidelines within major pharmaceutical markets driving competitive pricing
5.2. Implementation of single-use bioreactor technologies to accelerate development timelines and reduce cross-contamination risks
5.3. Integration of continuous manufacturing processes in monoclonal antibody production to enhance scalability and reduce costs
5.4. Expansion of gene therapy biologics pipelines with novel viral vector platforms targeting rare genetic disorders
5.5. Application of AI-driven cell line development to optimize clone selection and improve bioprocess yields
5.6. Strategic partnerships between biopharma companies and CDMOs to expand capacity for high-potency biologics and gene therapies
5.7. Regulatory alignment across major markets facilitating global approvals of biosimilar and next-generation biologic therapies
5.8. Growing investment in novel delivery platforms for protein therapeutics to improve patient adherence and pharmacokinetics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biologics Market, by Product Type
8.1. Introduction
8.2. Blood Factor Products
8.3. Cell Therapies
8.3.1. CAR-T Therapies
8.3.2. Stem Cell Therapy
8.4. Gene Therapies
8.5. Monoclonal Antibodies
8.6. Recombinant Proteins
8.7. Vaccines
9. Biologics Market, by Technology
9.1. Introduction
9.2. Cell Culture Technology
9.3. Gene Editing Technology
9.3.1. CRISPR
9.3.2. TALENs
9.3.3. Zinc Finger Nucleases
9.4. Hybridoma Technology
9.5. Recombinant DNA Technology
10. Biologics Market, by Route Of Administration
10.1. Introduction
10.2. Intramuscular
10.3. Intravenous
10.4. Subcutaneous
11. Biologics Market, by Therapeutic Area
11.1. Introduction
11.2. Autoimmune
11.3. Cardiovascular Diseases
11.4. Infectious Diseases
11.5. Metabolic Disorders
11.6. Neurological Disorders
11.7. Oncology
12. Biologics Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Home Healthcare
12.4. Hospitals
12.5. Research Institutes
13. Biologics Market, by Distribution Channel
13.1. Introduction
13.2. Hospital Pharmacy
13.3. Online Channel
13.4. Retail Pharmacy
14. Americas Biologics Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Biologics Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Biologics Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Roche Holding AG
17.3.2. AbbVie Inc.
17.3.3. Pfizer Inc.
17.3.4. Johnson & Johnson
17.3.5. Novartis AG
17.3.6. Merck & Co., Inc.
17.3.7. Sanofi S.A.
17.3.8. Amgen Inc.
17.3.9. Bristol-Myers Squibb Company
17.3.10. Gilead Sciences, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOLOGICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOLOGICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOLOGICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOLOGICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIOLOGICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. BIOLOGICS MARKET: RESEARCHAI
FIGURE 28. BIOLOGICS MARKET: RESEARCHSTATISTICS
FIGURE 29. BIOLOGICS MARKET: RESEARCHCONTACTS
FIGURE 30. BIOLOGICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOLOGICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOLOGICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICS MARKET SIZE, BY BLOOD FACTOR PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICS MARKET SIZE, BY BLOOD FACTOR PRODUCTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICS MARKET SIZE, BY CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICS MARKET SIZE, BY CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICS MARKET SIZE, BY CAR-T THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICS MARKET SIZE, BY CAR-T THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICS MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOLOGICS MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICS MARKET SIZE, BY GENE THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICS MARKET SIZE, BY GENE THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICS MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOLOGICS MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICS MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOLOGICS MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOLOGICS MARKET SIZE, BY CRISPR, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOLOGICS MARKET SIZE, BY CRISPR, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOLOGICS MARKET SIZE, BY TALENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOLOGICS MARKET SIZE, BY TALENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOLOGICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOLOGICS MARKET SIZE, BY HYBRIDOMA TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOLOGICS MARKET SIZE, BY HYBRIDOMA TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOLOGICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOLOGICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOLOGICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOLOGICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOLOGICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOLOGICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOLOGICS MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICS MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOLOGICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOLOGICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOLOGICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOLOGICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOLOGICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOLOGICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOLOGICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOLOGICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOLOGICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOLOGICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOLOGICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOLOGICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOLOGICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOLOGICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOLOGICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIOLOGICS MARKET SIZE, BY ONLINE CHANNEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIOLOGICS MARKET SIZE, BY ONLINE CHANNEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIOLOGICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIOLOGICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS BIOLOGICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES BIOLOGICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES BIOLOGICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 123. CANADA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. CANADA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. CANADA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 126. CANADA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 127. CANADA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 128. CANADA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 129. CANADA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 130. CANADA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 131. CANADA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 132. CANADA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 133. CANADA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 134. CANADA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 135. CANADA BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. CANADA BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. CANADA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. CANADA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. MEXICO BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. MEXICO BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 142. MEXICO BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 143. MEXICO BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 144. MEXICO BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 145. MEXICO BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 146. MEXICO BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 147. MEXICO BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. MEXICO BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. MEXICO BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 150. MEXICO BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 151. MEXICO BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. MEXICO BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. MEXICO BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. MEXICO BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. GERMANY BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. GERMANY BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. GERMANY BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 224. GERMANY BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 225. GERMANY BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. GERMANY BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. GERMANY BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 228. GERMANY BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 229. GERMANY BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. GERMANY BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 231. GERMANY BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 232. GERMANY BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 233. GERMANY BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. GERMANY BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. GERMANY BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. GERMANY BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. FRANCE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. FRANCE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. FRANCE BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 240. FRANCE BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 241. FRANCE BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 242. FRANCE BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 243. FRANCE BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. FRANCE BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. FRANCE BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 246. FRANCE BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 247. FRANCE BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 248. FRANCE BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 249. FRANCE BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. FRANCE BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. FRANCE BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. FRANCE BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. ITALY BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. ITALY BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. ITALY BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 272. ITALY BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 273. ITALY BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 274. ITALY BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 275. ITALY BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 276. ITALY BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 277. ITALY BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 278. ITALY BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 279. ITALY BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 280. ITALY BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 281. ITALY BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. ITALY BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. ITALY BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. ITALY BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. SPAIN BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. SPAIN BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. SPAIN BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 288. SPAIN BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 289. SPAIN BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 290. SPAIN BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 291. SPAIN BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 292. SPAIN BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 293. SPAIN BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 294. SPAIN BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 295. SPAIN BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 296. SPAIN BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 297. SPAIN BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. SPAIN BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. SPAIN BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. SPAIN BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 320. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 322. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 324. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 326. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 328. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 334. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 335. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 336. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 337. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 338. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 339. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 340. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 341. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 342. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 343. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 344. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 345. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 346. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 347. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 348. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 349. DENMARK BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 350. DENMARK BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 351. DENMARK BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 352. DENMARK BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 353. DENMARK BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 354. DENMARK BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 355. DENMARK BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 356. DENMARK BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 357. DENMARK BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 358. DENMARK BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 359. DENMARK BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 360. DENMARK BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 361. DENMARK BIOLOGICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 362. DENMARK BIOLOGICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 363. DENMARK BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 364. DENMARK BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 365. NETHERLANDS BIO

Samples

Loading
LOADING...

Companies Mentioned

  • Roche Holding AG
  • AbbVie Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • Novartis AG
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 459.45 Billion
Forecasted Market Value ( USD ) by 2030 $ 626.76 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Cancer Biologics Market - Global Forecast 2025-2030 - Product Image

Cancer Biologics Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Translational Regenerative Medicine Market - Global Forecast 2025-2030 - Product Image

Translational Regenerative Medicine Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Biologics Regulatory Affairs Outsourcing Market Size, Share & Trends Analysis Report By Service, By Phase, By Modality, Phase by Service, Phase by Modality, Modality by Service, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Biologics Regulatory Affairs Outsourcing Market Size, Share & Trends Analysis Report By Service, By Phase, By Modality, Phase by Service, Phase by Modality, Modality by Service, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Biologics - Global Strategic Business Report - Product Image

Biologics - Global Strategic Business Report

  • Report
  • 293 Pages
  • Global
From
Biologics Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034 - Product Image

Biologics Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.